Executive Summary: There aren’t any.內容提要：有沒有。

The first potential alternative is a promising breakthrough in the biotech world of stem cell research with the news that Harvard scientists reported taking skincells to generate embryonic stem cells.第一個潛在的替代是一種很有前途的突破，在生物技術的世界幹細胞研究與消息說，哈佛大學的科學家報告說，它們採取skincells產生胚胎幹細胞。

Researcher Kevin Eggan and his colleagues achieved this研究員凱文eggan和他的同事們實現了這個
dramatic medical advance by fusing individual adult skin cells and bone戲劇性的醫療提前融合個別成人皮膚細胞和骨
cells to embryonic cells.細胞的胚胎細胞。

However Eggan estimates it may be as much as ten years before this method can be used in treatment.不過eggan估計，它可能高達十幾年前，這個方法可以用來治療。 His complete report appeared in the journal Science on-line on August 22.他的完整的報告出現在科學雜誌上線於8月22日。

Additionally in a New York Times article, it is reported that scientists would need to uncover how to reprogram the chromosomes of the cell´s nucleus.此外，在一個新的紐約時報文章，有報導說，科學家將需要揭露如何reprogram染色體的細胞核。 The fused cells may have twice the number of chromosomes of the original cell, thus the cell may not survive.體細胞可能有兩倍數量的染色體上的原始細胞，因此，細胞可能無法生存。

This simply doesn’t help in any way with the current requirements of stem cells for treating diseases like Parkinson’s, diabetes, Multiple Sclerosis, heart disease, spinal cord injuries etc.這根本無助於以任何方式與現行規定的幹細胞用於治療疾病，如帕金森，糖尿病，多發性硬化，心髒病，脊髓損傷等。

“We are right where we always were,” said Sen. Tom Harkin, D-Iowa, a co-sponsor of the bill with Sen. Arlen Specter, R-Pa., on Monday after having read of the Harvard research. "我們正在正確的，我們一直都是說： "參議員湯姆harkin和D -愛荷華，共同贊助這項條例草案，參議員斯佩克特，俄149人，上週一後，在拜讀過的哈佛研究。

The second alternative is第二個辦法是 cordblood-derived-embryonic like stem cells or CBE’s cordblood源性-胚胎樣幹細胞或斷路器的 . 。 They are better than adult stem cells but the newfound CBEs are nowhere as versatile as human embryonic stem cells.他們均優於成體幹細胞，但新發現的cbes是行不通的，因為多才多藝，作為人類胚胎幹細胞。

In short embryonic stem cells currently do not have any alternatives in treatment of life-threatening diseases.在簡短的胚胎幹細胞，目前也沒有任何替代治療威脅生命的疾病。